West Pharmaceutical Services (NYSE:WST – Get Free Report) updated its third quarter 2026 earnings guidance on Thursday. The company provided earnings per share guidance of 2.140-2.240 for the period, compared to the consensus earnings per share estimate of 2.130. The company issued revenue guidance of $820.0 million-$835.0 million, compared to the consensus revenue estimate of […]

Equities research analysts at BNP Paribas Exane began coverage on shares of West Pharmaceutical Services (NYSE:WST – Get Free Report) in a report released on Monday, Marketbeat.com reports. The brokerage set an “outperform” rating and a $447.00 price target on the medical instruments supplier’s stock. BNP Paribas Exane’s price objective points to a potential upside […]